We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current HEB market cap is 114.67M. The company's latest EPS is USD -0.2719 and P/E is -0.33.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 65k | 40k | 50k | 35k | 45k |
| Operating Income | -14.03M | -5.73M | -3.69M | -4.67M | -5.68M |
| Net Income | -12.58M | -5.82M | -1.84M | -3.88M | -5.79M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 163k | 135k | 141k | 202k | 170k |
| Operating Income | -15.02M | -17.06M | -19.92M | -31.92M | -19.77M |
| Net Income | -14.4M | -19.13M | -19.45M | -28.96M | -17.32M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 19.38M | 16.19M | 15.72M | 13.59M | 8.61M |
| Total Liabilities | 9.15M | 11.36M | 9.61M | 10.68M | 9.93M |
| Total Equity | 10.23M | 4.83M | 6.1M | 2.91M | -1.32M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 64.58M | 57.7M | 40.49M | 19.38M | 8.61M |
| Total Liabilities | 3.29M | 820k | 2.02M | 9.15M | 9.93M |
| Total Equity | 61.29M | 56.88M | 38.47M | 10.23M | -1.32M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -21.27M | -4.82M | -7.82M | -10.93M | -14.89M |
| Investing | -832k | -158k | 668k | 1M | 4.71M |
| Financing | 485k | 2.83M | 5.27M | 5.41M | 6.44M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -10.37M | -13.97M | -16.11M | -21.27M | -14.89M |
| Investing | -9.16M | -631k | 10.99M | -832k | 4.71M |
| Financing | 56.56M | 8.19M | 80k | 485k | 6.44M |
| Market Cap | 114.67M |
| Price to Earnings Ratio | -0.33 |
| Price to Sales Ratio | 33.33 |
| Price to Cash Ratio | 3.37 |
| Price to Book Ratio | -4.34 |
| Dividend Yield | - |
| Shares Outstanding | 63.71M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.2 (10.15%) |
| Company Name | Hemispherx Biopharma Inc New |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.aimimmuno.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
